Life stem cell therapy Purtier
9 years old girl benefited from deer placenta.

By: Keith Chew

See the original post:
Life stem cell therapy Purtier - Video

Recommendation and review posted by Bethany Smith

[NewsLife] Daily Dose: White blood cell therapy
NewsLife - Daily Dose: White blood cell therapy (Reported By: Jackie Say) - [July 11, 2013] For more news, visit: #9659;http://www.ptvnews.ph Download our mobile ...

By: PTV PH

See original here:
[NewsLife] Daily Dose: White blood cell therapy - Video

Recommendation and review posted by Bethany Smith

Cell Therapy Brunch -Dr Van Natta

By: Ryan Alan Petti

Visit link:
Cell Therapy Brunch -Dr Van Natta - Video

Recommendation and review posted by Bethany Smith

Genetic Engineering Karen
Speech class.

By: karen lehmiller

See the original post:
Genetic Engineering Karen - Video

Recommendation and review posted by Bethany Smith

Seventy percent of items in American grocery stores contain genetically modified organisms (GMOs) ingredients that have been scientifically engineered in laboratories to enhance certain traits such as insect, disease and water resistance.

Genetic engineering is a recent technique that involves being able to take genetic material from one organism and put it into another when the two wouldnt normally be cross-compatible, said Margaret Smith, associate director for the Cornell University Agricultural Experiment Station.

There are four major genetically modified crops: corn, soy bean, cotton and canola. According to Smith, this type of technology can be useful.

We're facing increasing stresses from more erratic weather and new and different pests that move in, Smith said. I think in that regard we're going to need every possible tool we can get to help make our crops as productive as they possibly can be.

GMOs have only been on the market since 1995, but theyve recently sparked a national debate over the potential impact they could have on the environment and our health.

Dr. Michael Wald, of Integrated Medicine of Mount Kisco in New York, said more research needs to be done in order to prove that genetically engineered foods are safe to eat.

The studies that have been done on different animals and also reports from farmers seem to suggest health issues, including intestinal problems, inflammation of the colonand problems with the kidneys, the liver, the lungs, Wald said.

Smith also agreed that research is key when it comes to assessing the safety of GMOs.

None of the products out there have shown any evidence, over the 15 plus years theyve been (on the) market, of human health concerns, Smith said. So, I find that reassuring in terms of food safety. That doesnt say that new products shouldnt be looked at very carefully.

The Food and Drug Administration has approved over 40 seeds and plants for genetic modifications but the agency leaves the safety assessments up to the companies. However, more and more Americans are asking for GMO products to be labeled - and for the right to know what exactly they are eating.

See more here:
GMO Safety Debated

Recommendation and review posted by Bethany Smith

Gregor Mendel - Mini Biography
Watch a short biography video of Gregor Mendel, best known as "The Father of Modern Genetics." Learn more about Gregor Mandel: http://bit.ly/14E19iS Watch mo...

By: BiographyChannel

Go here to read the rest:
Gregor Mendel - Mini Biography - Video

Recommendation and review posted by Bethany Smith

Hard Work VS Genetics - Which One Wins?
http://www.IllPumpYouUp.com Tim Muriello, Competitive Bodybuilder and Fitness and Supplement Expert for I #39;llPumpYouUp.com, brings up a very debatable question...Har...

By: IllPumpYouUpcom

See original here:
Hard Work VS Genetics - Which One Wins? - Video

Recommendation and review posted by Bethany Smith

Shardul Trivedi MSc Prenatal Genetics and Fetal Medicine
For more information please visit: http://www.instituteforwomenshealth.ucl.ac.uk/

By: StudyUCL

The rest is here:
Shardul Trivedi MSc Prenatal Genetics and Fetal Medicine - Video

Recommendation and review posted by Bethany Smith

X-47B Completes First Carrier-based Arrested Landing
The X-47B Unmanned Combat Air System (UCAS) demonstrator completed its first carrier-based arrested landing on board USS George H.W. Bush (CVN 77) off the co...

By: U.S. Navy

Follow this link:
X-47B Completes First Carrier-based Arrested Landing - Video

Recommendation and review posted by Bethany Smith

Council of Europe Journal (Week 14)
04/04/2013 - The Week 14 edition includes a look at corruption in Moldova and interviews with Anastasia Nani and Michael Janssen. Susanne Keitel talks about ...

By: CouncilofEurope

See original here:
Council of Europe Journal (Week 14) - Video

Recommendation and review posted by Bethany Smith

The Therapy explained by Luigi Naldini
http://www.telethon.it/en - The gene therapy developed by researchers at the Telethon Institute of Milan consists in administering a correct version of the g...

By: Telethonitalia

Go here to read the rest:
The Therapy explained by Luigi Naldini - Video

Recommendation and review posted by Bethany Smith

#39;Defanged #39; HIV Used To Deliver Gene Therapy
#39;Defanged #39; HIV Used To Deliver Gene Therapy Researchers are having success using a vector that is derived from HIV to deliver gene therapy to children suffer...

By: WochitGeneralNews

Read the rest here:
'Defanged' HIV Used To Deliver Gene Therapy - Video

Recommendation and review posted by Bethany Smith

Breaking News Headlines: #39;Defanged #39; HIV Used To Deliver Gene Therapy
#39;Defanged #39; HIV Used To Deliver Gene Therapy Researchers are having success using a vector that is derived from HIV to deliver gene therapy to children suffer...

By: WochitGeneralNews

Originally posted here:
Breaking News Headlines: 'Defanged' HIV Used To Deliver Gene Therapy - Video

Recommendation and review posted by Bethany Smith

Aram Boghosian for The Boston Globe Kirsti Pigney is participating in a trial for gene therapy to treat blindness. She cant tell whether the therapy is working, but said her vision hasnt worsened.

By Carolyn Y. Johnson / Globe Staff/ July 13, 2013

Years after it was hyped, vilified for the death of a teenager, and then mostly forgotten by the general public, gene therapy has rebounded, and hospitals, companies, and investors in the Boston area have jumped on the bandwagon.

Patients are enrolling in a growing number of clinical trials here, and in some cases showing dramatic improvement. The technique, in which doctors infect patient cells with viruses engineered to carry useful genes, has matured and evolved.

Once trumpeted as a possible panacea for diseases ranging from sickle cell anemia to cystic fibrosis, gene therapy faced serious questions after the high-profile death of a Pennsylvania teenager in a clinical trial in 1999. But some researchers continued to work to overcome the safety and technical hurdles. Full story for BostonGlobe.com subscribers.

Copyright 2013 Globe Newspaper Company.

Get the full story with unlimited access to BostonGlobe.com. Just 99 for 4 weeks.

Get Access Now

See the rest here:
Testing of gene therapies expanding at Boston-area hospitals

Recommendation and review posted by Bethany Smith

Aram Boghosian for The Boston Globe Kirsti Pigney is participating in a trial for gene therapy to treat blindness. She cant tell whether the therapy is working, but said her vision hasnt worsened.

By Carolyn Y. Johnson / Globe Staff/ July 13, 2013

Years after it was hyped, vilified for the death of a teenager, and then mostly forgotten by the general public, gene therapy has rebounded, and hospitals, companies, and investors in the Boston area have jumped on the bandwagon.

Patients are enrolling in a growing number of clinical trials here, and in some cases showing dramatic improvement. The technique, in which doctors infect patient cells with viruses engineered to carry useful genes, has matured and evolved.

Once trumpeted as a possible panacea for diseases ranging from sickle cell anemia to cystic fibrosis, gene therapy faced serious questions after the high-profile death of a Pennsylvania teenager in a clinical trial in 1999. But some researchers continued to work to overcome the safety and technical hurdles. Full story for BostonGlobe.com subscribers.

Copyright 2013 Globe Newspaper Company.

Get the full story with unlimited access to BostonGlobe.com. Just 99 for 4 weeks.

Get Access Now

See more here:
Testing of gene therapies expanding at Boston-area hospitals - Boston.com

Recommendation and review posted by Bethany Smith

Spinal Cord Injury Accident: Expert Legal Tips for Recovery
http://www.jurewitz.com Ross Jurewitz, founder and head personal injury attorney at the Jurewitz Law Group, shares how to properly identify and handle a potential s...

By: JurewitzLawGroup

Excerpt from:
Spinal Cord Injury Accident: Expert Legal Tips for Recovery - Video

Recommendation and review posted by sam

Bone Marrow Stem Cells Help Cerebral Palsy - Andrew #39;s Testimony
Watch Andrew #39;s Testimonial on how adult bone marrow stem cells helped him and his cerebral palsy. Stem cells are helping cerebral palsy patients today includ...

By: David Steenblock

Read the original post:
Bone Marrow Stem Cells Help Cerebral Palsy - Andrew's Testimony - Video

Recommendation and review posted by Bethany Smith

Habib Torfi and stem cell therapy at Invitrx Therapeutics
Stem Cell Therapy.

By: Habib Torfi

See the article here:
Habib Torfi and stem cell therapy at Invitrx Therapeutics - Video

Recommendation and review posted by Bethany Smith

Cell Therapy Brunch- Traci Runge

By: Ryan Alan Petti

Read the original post:
Cell Therapy Brunch- Traci Runge - Video

Recommendation and review posted by Bethany Smith

Home Mail News Sports Finance Weather Games Groups Answers Flickr More omg! Shine Movies Music TV Health Shopping Travel Autos Homes Search News Search Web Sign In Mail Help Account Info Help Suggestions Yahoo! Home Video Photos GMA Year in Review LiveRoom Odd Comics Travel Opinion Trending Now Who Knew? Weather The Upbeat U.S. U.S. Video GMA Education Religion Crimes and Trials The Lookout Local Contributor Network Year In Review World World Video Middle East Europe Latin America Africa Asia Canada Australia/Antarctica Business Video Exclusives Today's Markets Stocks Personal Finance Marketplace Entertainment Video Clinton Concert Celebrity TV Movies Music Fashion Books Arts Theater Dear Abby Comics Odd News Sports Video NFL MLB NBA NCAAF NCAAB Soccer Cycling NHL Tennis Golf Boxing Motor Sports MMA Olympics Tech Gadgets Wireless Apple Social Media Security Open Source Gaming Apps This Could Be Big Upgrade Your Life Politics Remake America The Issues Women and Politics Press Releases Video Science Science Video Weather News Space / Astronomy Pets Dinosaurs / Fossils Biotech Energy Green Health Video Weight Loss Cancer Sexual Health Medications/Drugs Parenting/Kids Seniors/Aging Diseases/Conditions Blogs The Lookout The Sideshow Around the World Katie's Take Power Players This Could Be Big Newsmakers Trending Now Just Explain It The Upbeat Local Popular Search Keyword News Search Featured Videos Photos Just Explain It Katie's Take Weather The Upbeat Newsmakers

Link:
Alnylam bets on 'gene silencing' to woo biotech investors

Recommendation and review posted by Bethany Smith

July 12, 2013

St. Olaf students Heena Joo 16 (seated) and Petra Hahn 14 (right) are working with Assistant Professor of Biology Lisa Bowers (left) this summer to discover the purpose of a gene they deleted from a common type of bacteria. Using this simple bacteria as a stepping stone could be key in future application to other fields such as embryology and stem cell research.

When researchers at St. Olaf College deleted a single gene from a common type of bacteria, they dramatically altered the cell cycle of the organism. In the process, they created a mutant that had never been studied before.

Theyre hoping this research will help scientists better understand what sort of genes control the cell cycle and for what purpose.

Students in Assistant Professor of Biology Lisa Bowers research class first isolated this important gene back in January. The bacterial species theyre studying, Caulobacter crescentus, usually undergoes two phases of its cell cycle. During the first phase, the cells have a flagellum, a tail-like structure that helps them swim and look for food. When the cells enter the second phase, they shed the flagellum and grow a long sticky stalk, which allows them to stick to surfaces.

The students discovered that deleting the novel gene prevented Caulobacter from growing a stalk during the second phase of its life cycle. This provided the basis for spring researchers Jonathon Peterson 14 and Margret Bradley 13 and summer researchers Petra Hahn 14 and Heena Joo 16 to examine the characteristics of the Caulobacter crescentus mutant.

The summer team, whose work is part of St. Olafs Collaborative Undergraduate Research and Inquiry program, is also working on re-inserting this stalkless gene back into the mutant cell through a process called gene complementation.

To our knowledge, nobody has ever studied this gene before, so part of our summer research is to figure out what it encodes exactly, says Bowers.

Caulobacter works well as a model organism since its short life cycle is characterized by easy-to-see changes. This gives researchers a simpler model to study than, say, a human cell line. Using this simple bacteria as a stepping stone could be key in future application to other fields such as embryology and stem cell research.

Link:
Researchers work to discover purpose of deleted gene

Recommendation and review posted by Bethany Smith

July 12, 2013

[ Watch the Video: Gene Therapy Used By San Raffaele Telethon Institute For Gene Therapy ]

redOrbit Staff & Wire Reports Your Universe Online

The virus that causes AIDS has been used to cure a pair of different genetic diseases, according to research published Thursday in the journal Science.

In the studies, Luigi Naldini, director of the San Raffaele Telethon Institute for Gene Therapy (TIGET) in Italy, and his colleagues report they successfully used HIV to cure metachromatic leukodystrophy and Wiskott-Aldrich syndrome in a total of six children, all of whom are reportedly in good health.

Three years after the start of the clinical trial, the results obtained from the first six patients are very encouraging: the therapy is not only safe, but also effective and able to change the clinical history of these severe diseases, Naldini said in a statement. After 15 years of effort and our successes in the laboratory, but frustration as well, its really exciting to be able to give a concrete solution to the first patients.

The idea to use HIV as a potential treatment option for these two genetic diseases first came about in 1996. Both conditions have, at their core, a genetic defect that causes a deficiency in a protein essential for the patient during the early years of his or her life. In metachromatic leukodystrophy, the nervous system is affected and over time children lose cognitive and motor skills, while in Wiskott-Aldrich syndrome, a faulty immune system results, making the child prone to infections, autoimmune diseases and cancer, the researchers explained.

After several years of laboratory study produced positive results, the TIGET researchers attempted to correct the genetic defect that causes these diseases with gene therapy. The technique required to do so involves the withdrawal of hematopoietic stem cells from the patients bone marrow, then introducing a corrected copy of the gene that is defective using viral vectors derived from HIV. They are then re-injected into the body, allowing the cells to start restoring the missing protein to vital organs.

In patients with Wiskott-Aldrich syndrome, blood cells are directly affected by the disease and the corrected stem cells replace the diseased cells creating a properly functioning immune system and normal platelets, said study coordinator and Head of Research at TIGERs Pediatric Clinic Alessandro Aiuti. Thanks to gene therapy, the children no longer have to face severe bleeding and infection. They can run, play and go to school.

In the case of metachromatic leukodystrophy, however, the therapeutic mechanism is more sophisticated: the corrected hematopoietic cells reach the brain through the blood and release the correct protein that is gathered there by the surrounding nerve cells, added Alessandra Biffi, who led the other study. The winning card was to make engineered cells able to produce a quantity of protein much higher than normal, and thus effectively counteract the neurodegenerative process.

Go here to see the original:
HIV Virus Used To Cure Two Genetic Diseases

Recommendation and review posted by Bethany Smith

Results for Life, the education and advocacy branch of the American Clinical Laboratory Association, held a briefing on Capitol Hill yesterday to shine a spotlight on the value of genetic and genomic testing, and to explain the importance of funding genomics and biomedical research to lawmakers and staff members.

The event included Rep. Jackie Speier (D - Calif.), who praised genetic testing as having "saved many lives," and called for more research to develop new tests for more types of cancer and other diseases.

"Thanks to results of the human genome project and genomic testing, we're seeing results that allow for real personalized medicine," said Speier, who also encouraged her fellow lawmakers to learn more about these advances, and to "support full funding for the National Institutes of Health...."

Speier, who is co-chair of the House Biomedical Research Caucus, said that many chemotherapy patients see little or no benefit from their treatments, but that genome-based testing will enable doctors to "know when it is going to work, and why it is going to work," on some patients and not others.

Noting the importance of continued research to develop new tests, she explained that NIH Director Francis Collins has said that China will eclipse the US as the leader in genome sequencing in three to five years.

"Now, that should be a warning sign to all of us that if we don't continue to fund NIH and medical research in this country, [then China] will eclipse us. And when they eclipse us, much of the research and technology will leave the US and relocate to China, and we don't want that to happen," Speier said.

Speier was joined by Genomic Health's Steven Shak, who is the company's CMO and executiv VP for R&D, and by a patient advocate with firsthand experience with how genetic testing - the Oncotype Dx test - helped to save her life.

Shak said it is "extremely challenging" to develop such tests, and it takes collaboration and teamwork.

"There is no such thing now as little science. There is big science and big data," he said.

He delivered a background on what the Oncotype test is, how it works, and how widely it is used today, and explained that it required a partnership between industry, government, patient advocates, and academia to develop this test and others like it.

See more here:
Genetic Testing Session on Capitol Hill

Recommendation and review posted by Bethany Smith

Professor Robin Feldman on SCOTUS Myriad Genetics Decision

By: InnovationLaw

Go here to see the original:
Professor Robin Feldman on SCOTUS Myriad Genetics Decision - Video

Recommendation and review posted by Bethany Smith

Annual Research Forum - Familial genetics -- what you need to know by Mary-Anne Young
Mary-Anne Young speaking on Familial genetics -- #39;what you need to know #39; at the joint Annual Research Forum held with Ovarian Cancer Australia and Prostate C...

By: OCAustralia

Originally posted here:
Annual Research Forum - Familial genetics -- what you need to know by Mary-Anne Young - Video

Recommendation and review posted by Bethany Smith